Montelukast in Chronic Asthma

Montelukast in Chronic Asthma: Non-interventional Study With Montelukast 10 mg

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00802789

Enrollment

2000

Registered

2008-12-05

Start date

2007-04-30

Completion date

2008-10-31

Last updated

2022-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Treatment of patients insufficiently treated with ICS or ICS + LABA.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients Insufficiently Treated With ICS Or ICS + LABA.

Design outcomes

Primary

Measure	Time frame
Documentation of asthma control via ACT (Asthma Control Test).	6 months (12 months optional)

Secondary

Measure	Time frame
Mini Asthma Quality of Life Questionnaire (Mini AQLQ).	6 months (12 months optional)

Outcome results